Comparative enzymatic hydrolysis of porcine tracheal cartilage generates ACE/DPP-IV-inhibitory and antioxidant peptides with enhanced bioactivity following simulated gastrointestinal digestion and molecular docking analysis
Aug 2026· Food Chemistry: X· Vol 38, pp. 104298· 0 citations· 46 references
Medicine
TL;DR
Standardised INFOGEST gastrointestinal digestion progressively enhanced ACE inhibition and antioxidant activities while DPP-IV inhibition declined, establishing porcine tracheal cartilage as a viable source of gastrointestinally stable cardiovascular bioactive peptides.
Abstract
Porcine tracheal cartilage, an underutilized Type II collagen-rich by-product, was systematically evaluated as a source of angiotensin I-converting enzyme (ACE) inhibitory, dipeptidyl peptidase-IV (DPP-IV) inhibitory, and antioxidant peptides. Neutrase at 4 h outperformed Papain in generating ACE-inhibitory and antioxidant peptides. The <3 kDa ultrafiltration fraction, enriched in small hydrophobic peptides, exhibited the highest bioactivities. LC-MS/MS identified eight sequences (870–1565 Da). Chemical synthesis confirmed LGLGADMFHR as the most potent ACE inhibitor (IC50 = 0.52 mM), QGLPGPGAVAEYT as the lead DPP-IV inhibitor (IC50 = 1.84 mM), and LGFGADRAGPQ as the strongest antioxidant (5.64 mM Trolox equivalents). Molecular docking revealed LGLGADMFHR binding through Zn2+ coordination and hydrogen bonds with Cys352, Glu376, and Asp453. Standardised INFOGEST gastrointestinal digestion progressively enhanced ACE inhibition and antioxidant activities while DPP-IV inhibition declined, establishing porcine tracheal cartilage as a viable source of gastrointestinally stable cardiovascular bioactive peptides.
Across both in vitro and in vivo models, ultra-low molecular weight collagen (LMWCP), with more than 45% di- and tripeptides, exhibited faster early-phase absorption kinetics, thereby enhancing early-phase bioavailability.
Reyhan Nergiz-Unal, Stephan Dierckx, C. Roye et al.· PeerJ· 0 citations
Peanut peptides (PP) are promising plant-derived functional ingredients, but bitterness and gastrointestinal instability limit oral applications. This study integrated complex enzymolysis, LC-MS/MS-assisted in silico screening, molecular dynamics (MD), and W1/O/W2 double-emulsion microencapsulation to establish a laboratory-scale discovery-to-delivery workflow for antioxidant PP. Under optimized alkaline protease/flavor protease hydrolysis (5:5, w/w; 10% enzyme; 59 °C; 9 h), LC-MS/MS identified 763 peanut-derived peptides. Stepwise screening using PeptideRanker (>0.5), ToxinPred3.0 (<0.5), and AlgPred2.0 (<0.5) yielded 157 candidates. CDOCKER docking identified P152 (FEELNADLFR) and P142 (YFPTQALNFAFK) as the top docking-ranked Keap1-Kelch and MPO candidates, respectively, with CDOCKER energies of -163.791 and - 158.855 kcal/mol; P34 (SPNVDPPKTP) and P135 (IPVPFPDPDGDYT) showed the lowest calculated binding energies with ABTS+ and DPPH, respectively. MD/MM-PBSA further supported dynamic stability and favorable binding tendencies of P152-Keap1-Kelch and P142-MPO complexes. The optimized PP-loaded double-emulsion microcapsule (PP-M) showed high apparent encapsulation efficiency (89.43%, nitrogen-balance estimate). Human sensory evaluation and electronic-tongue analysis demonstrated that PP-M significantly reduced perceived bitterness and instrumental bitterness response compared with free PP hydrolysate at matched peptide-equivalent concentration. Static INFOGEST digestion indicated gastric structural retention followed by intestinal disintegration, accompanied by increased peptide-equivalent content and enhanced radical-scavenging activity in the digesta. Overall, PP-M improved the in vitro sensory acceptability and bioaccessibility of PP, supporting formulation-level bitterness alleviation rather than complete bitterness elimination. Targeted bitter-peptide identification, marker-peptide release profiling, epithelial transport, and in vivo validation remain necessary.
Chengli Jia, Yansheng Wang, Tiantian Ran et al.· Food Research International· 0 citations
This study investigates the ultrasound-assisted enzymatic extraction of collagen hydrolysates (CH) from chicken skin, heads, and feet, aiming to generate bioactive peptides with potent antioxidant activity. Process optimization involved acetic acid pre-treatment, ultrasonication (39 kHz), and enzymatic hydrolysis using collagenase, followed by ultrafiltration (10 kDa). The optimized treatment (T2) yielded hydrolysates with a high degree of hydrolysis (85.31%) and protein content (11.73 g/dL). SDS-PAGE revealed predominantly low-molecular-weight peptides, indicative of effective collagen breakdown. Antioxidant capacity, measured via DPPH and ABTS+ assays, was significantly elevated in T2 (76.38% and 91.41%, respectively). Peptidomic profiling was conducted using LC-ESI-MS/MS on a QTOF mass spectrometer, enabling the identification of numerous peptide sequences. In-silico bioactivity prediction using the BIOPEP database and Peptide Ranker algorithm revealed multiple sequences with high antioxidant potential, particularly short-chain peptides rich in hydrophobic and aromatic residues. The integration of advanced proteomic tools and bioinformatic analyses confirmed the efficacy of ultrasound-assisted enzymatic hydrolysis in producingfunctionally relevant peptides. These findings support the valorization of poultry by-products as a sustainable source ofantioxidative peptides for potential applications in food and health sectors.
Sucheta Roy, Rituparna Banerjee, N. B. Maheswarappa et al.· Journal of Meat Science· 0 citations
Skin aging involves the progressive dysregulation of extracellular matrix-degrading enzymes and oxidative stress pathways, driving demand for biologically characterized cosmeceutical ingredients. This study provides the first direct comparative evaluation of apilarnil , a lyophilized drone larvae-derived bee product (Apis mellifera) and acetyl hexapeptide-3 (Argireline®; Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂), a synthetic neurotransmitter inhibitor peptide, with respect to total antioxidant capacity, elastase, collagenase, and human tyrosinase inhibitory activities, and cytotoxicity toward HaCaT human keratinocytes. Compositional characterization of apilarnil revealed a protein-rich profile (42.67 g/100 g) containing 16 amino acids, multiple vitamins, and mineral constituents. Acetyl hexapeptide-3 exhibited higher total antioxidant capacity (5304.7 ± 103.9 µM Trolox equivalents) compared to apilarnil (645.3 ± 23.3 µM TE), attributable to the abundance of electron-donating residues in its defined sequence. Acetyl hexapeptide-3 also produced potent, concentration-dependent inhibition of elastase (IC₅₀ = 1.534 mg/mL) and collagenase (IC₅₀ = 0.00811 mg/mL), whereas apilarnil displayed a biphasic hormetic dose–response for both enzymes, with low-dose activation followed by high-dose inhibition. Neither compound showed an apparent inhibitory effect on human tyrosinase in a single preliminary experiment (n = 1); given the lack of statistical replication, this finding should be considered exploratory and requires confirmatory replication. Cytotoxicity assessment demonstrated that apilarnil was non-toxic across all tested concentrations (0.3125–20 mg/mL; viability >90%), while acetyl hexapeptide-3 exhibited concentration-dependent cytotoxicity (CC₅₀ = 5.34% v/v). These findings reveal complementary bioactivity profiles between the two compounds, suggesting potential value in further investigating their combined use in cosmeceutical formulations.
Sibel Dikmen Küçük, M. Kekeçoğlu· Journal of Apitherapy and Na...· 0 citations
Dairy peptides and plant polyphenols attract significant attention for their bioactive properties; however, the synergistic antioxidant mechanism of buttermilk peptides and myricetin remains unclear. In this study, buttermilk proteins from Lacprodan MFGM-10, a milk fat globule membrane (MFGM)-enriched buttermilk powder, were subjected to multi-enzyme hydrolysis using papain (Pap), alkaline protease (AP), and neutral protease (NP) at an enzyme concentration of 6000 U/g in different combinations. The results showed that the synergistic application of enzymes significantly increased the degree of hydrolysis (DH), with the AP group reaching a peak DH of approximately 42% at 150 min. Two candidate peptides, WGSPP and SWPWQ, were selected from the screened buttermilk peptide fractions. Through Caco-2 transmembrane transport validation and molecular docking, it is confirmed that these peptides can non-competitively bind to acetylcholinesterase (AChE) via molecular docking, with binding energies of -12.7 and -11.1 kcal/mol, respectively. Additionally, myricetin exhibits a strong binding energy, with a binding energy of -9.5 kcal/mol. In an L6 myoblast injury model induced by rotenone, combined treatment significantly enhances AChE inhibitory rate, reduces reactive oxygen species (ROS) and malondialdehyde (MDA) levels, restores superoxide dismutase (SOD) activity and the NAD+/NADH ratio, and improves mitochondrial membrane potential and ATP levels, without demonstrating cytotoxicity. Buttermilk-derived peptides and myricetin exert synergistic antioxidant effects by improving redox homeostasis and mitochondrial function, thereby alleviating oxidative stress-induced injury in rotenone-induced L6 cells. These findings provide preliminary evidence for the potential role of these compounds in oxidative stress-associated skeletal muscle health; however, direct sarcopenia-related endpoints were not evaluated in the present study.
Wenjing Niu, Xiao-Lin Liu, Jiexia Bai et al.· Journal of Food Science· 0 citations